Filing Details
- Accession Number:
- 0001209191-21-021747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-18 16:05:15
- Reporting Period:
- 2021-03-16
- Accepted Time:
- 2021-03-18 16:05:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1357874 | Precision Biosciences Inc | DTIL | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769828 | Derek Jantz | C/O Precision Biosciences, Inc. 302 E. Pettigrew Street, Suite A-100 Durham NC 27701 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-16 | 21,514 | $0.04 | 3,967,207 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-16 | 9,661 | $11.97 | 3,957,546 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-03-17 | 21,514 | $0.04 | 3,979,060 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-17 | 9,665 | $10.92 | 3,969,395 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-03-16 | 21,514 | $0.00 | 21,514 | $0.04 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-03-17 | 21,514 | $0.00 | 21,514 | $0.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 172,112 | 2021-05-17 | No | 4 | M | Direct | |
| 150,598 | 2021-05-17 | No | 4 | M | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.92 to $11.98. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
